Investing

Glaukos : GKOS

GKOS

Stock Data

$186.63

$4.63 (2.54%)

Asset Type

Common Stock

Exchange

NYSE

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

MEDICAL DEVICES

Glaukos Corporation is a pioneer in eye care, focusing on innovative treatments for glaucoma, corneal disorders, and retinal diseases. Known for its iStent products, which are tiny stents used in cataract surgery to help manage glaucoma, the company is also developing new solutions like the iStent Infinite for severe glaucoma cases and iDose TR for reducing eye pressure. With a commitment to improving patients' vision and quality of life, Glaukos markets its products globally, combining medical technology with pharmaceutical therapies since its founding in 1998 in Aliso Viejo, California.

Latest Activity

GKOSGlaukos

Q2 2026

Jul 29, 4:10pm ET

EPS

-$0.14

est -$0.22+37.4%

Revenue

$186M

est $151M+22.9%

Glaukos crushed revenue expectations by 23% as iDose TR crossed $74 million in sales and Epioxa launched with $11 million in early traction, spurring the company to raise full-year guidance by $45 million to $680-700 million.

ShareRead more

All Glaukos Articles

0 Articles

No articles found for Glaukos.